HK1146464A1 - Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection - Google Patents

Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

Info

Publication number
HK1146464A1
HK1146464A1 HK11100290.4A HK11100290A HK1146464A1 HK 1146464 A1 HK1146464 A1 HK 1146464A1 HK 11100290 A HK11100290 A HK 11100290A HK 1146464 A1 HK1146464 A1 HK 1146464A1
Authority
HK
Hong Kong
Prior art keywords
low viscosity
triamcinolone acetonide
intravitreal injection
highly flocculated
suspensions
Prior art date
Application number
HK11100290.4A
Other languages
English (en)
Chinese (zh)
Inventor
Bhagwati P Kabra
Ruma Sarkar
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of HK1146464A1 publication Critical patent/HK1146464A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
HK11100290.4A 2008-03-11 2011-01-13 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection HK1146464A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3545908P 2008-03-11 2008-03-11
PCT/US2009/036652 WO2009114521A1 (en) 2008-03-11 2009-03-10 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

Publications (1)

Publication Number Publication Date
HK1146464A1 true HK1146464A1 (en) 2011-06-10

Family

ID=40548758

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11100290.4A HK1146464A1 (en) 2008-03-11 2011-01-13 Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection

Country Status (22)

Country Link
US (3) US8128960B2 (ru)
EP (1) EP2262506B1 (ru)
JP (1) JP5581227B2 (ru)
KR (1) KR101555293B1 (ru)
CN (1) CN101959519B (ru)
AR (1) AR070824A1 (ru)
AU (1) AU2009223649B2 (ru)
BR (1) BRPI0909630B8 (ru)
CA (1) CA2717605C (ru)
CL (1) CL2009000573A1 (ru)
DK (1) DK2262506T3 (ru)
ES (1) ES2471122T3 (ru)
HK (1) HK1146464A1 (ru)
MX (1) MX2010009974A (ru)
PL (1) PL2262506T3 (ru)
PT (1) PT2262506E (ru)
RU (1) RU2481842C2 (ru)
SI (1) SI2262506T1 (ru)
TW (1) TWI468165B (ru)
UY (1) UY31699A1 (ru)
WO (1) WO2009114521A1 (ru)
ZA (1) ZA201005839B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
MX2010009974A (es) * 2008-03-11 2010-09-30 Alcon Res Ltd Suspensiones de acetonida de triamcinolona de baja viscosidad, altamente floculadas para inyeccion intravitrea.
MX2011005586A (es) * 2008-12-22 2011-06-20 Alcon Res Ltd Composiciones de soluciones oculares topicas para suministrar concentraciones efectivas de agente activo al segmento posterior del ojo.
EP3520749A1 (en) 2010-10-15 2019-08-07 Clearside Biomedical, Inc. Device for ocular access
CN102008488B (zh) * 2010-11-24 2012-10-10 广州固志医药科技有限公司 一种曲安奈德眼用制剂及其制备方法
AR090775A1 (es) * 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
BR112015010566A2 (pt) * 2012-11-08 2017-07-11 Clearside Biomedical Inc métodos e dispositivos para o tratamento de doenças oculares em indivíduos humanos
WO2014179698A2 (en) 2013-05-03 2014-11-06 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
US10188550B2 (en) 2013-06-03 2019-01-29 Clearside Biomedical, Inc. Apparatus and methods for drug delivery using multiple reservoirs
RU2710491C2 (ru) 2014-06-20 2019-12-26 Клиасайд Байомедикал, Инк. Устройство для инъекции лекарственного средства в глазную ткань и способ инъекции лекарственного средства в глазную ткань
US9694145B1 (en) 2016-03-29 2017-07-04 Joseph Onorato Auto-injector systems and method for delivering cyst medication on demand
WO2017192565A1 (en) 2016-05-02 2017-11-09 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
IL264764B2 (en) 2016-08-12 2024-02-01 Clearside Biomedical Inc Devices and methods for adjusting the insertion depth of a drug administration needle
AU2019207515A1 (en) 2018-01-10 2020-07-30 Eye Co Pty Ltd Medical device and pharmaceutical composition for treatment of an eye disease or condition
USD893715S1 (en) 2018-11-06 2020-08-18 Joseph Onorato Measurement guide for a cyst, lesion or skin disorder
CA3136814A1 (en) * 2019-04-16 2020-10-22 Clearside Biomedical, Inc. Injectable triamcinolone formulations
US10799481B1 (en) * 2019-05-06 2020-10-13 Rvl Pharmaceuticals, Inc. Compositions and methods for treating ocular disorders
CN114010593A (zh) * 2021-11-23 2022-02-08 莱默(北京)药业科技有限公司 一种曲安奈德混悬注射液及制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962430A (en) * 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
US4370325A (en) * 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US5164190A (en) * 1990-12-11 1992-11-17 Theratech, Inc. Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
WO1995003807A1 (en) 1993-07-27 1995-02-09 The University Of Sydney Treatment of age-related macular degeneration
WO1996020712A1 (en) 1994-12-30 1996-07-11 American Home Products Corporation Clear non-alcoholic hydrocortisone solutions
JP2002520287A (ja) 1998-07-10 2002-07-09 ザ・ユニバーシティ・オブ・シドニー 黄斑変性における血管新生の予防的治療
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AUPQ496500A0 (en) 2000-01-06 2000-02-03 University Of Sydney, The Kit
US6395294B1 (en) 2000-01-13 2002-05-28 Gholam A. Peyman Method of visualization of the vitreous during vitrectomy
US6656505B2 (en) * 2000-07-21 2003-12-02 Alpharma Uspd Inc. Method for forming an aqueous flocculated suspension
EP1312356B1 (en) * 2000-08-25 2012-10-17 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations
NZ530764A (en) * 2001-07-09 2008-07-31 Combinatorx Inc Composition comprising a tricyclic antidepressant and a corticosteroid administered simutaneously or within 14 days for treatment of inflammatory disorders
US20030129242A1 (en) 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
CN1750828A (zh) * 2003-02-20 2006-03-22 爱尔康公司 类固醇治疗眼病患者的用途
US20040186084A1 (en) 2003-03-21 2004-09-23 Akorn, Inc. Triamcinolone formulations and methods for their preparation and use
JP2007506678A (ja) * 2003-09-23 2007-03-22 アルコン，インコーポレイテッド 注入のためのトリアムシノロンアセトアニドおよび酢酸アネコルタブの処方物
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050169992A1 (en) * 2003-12-23 2005-08-04 Frank Jao Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
CA2553381C (en) 2004-01-20 2011-03-22 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
CA2567411A1 (en) 2004-05-31 2005-12-08 Senju Pharmaceutical Co., Ltd. Transparent tissue-visualizing preparation
US20060089590A1 (en) 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
WO2006055954A2 (en) 2004-11-17 2006-05-26 Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Steroid formulation and methods of treatment using same
CA2598095A1 (en) 2005-02-18 2009-08-24 Santen Pharmaceutical Co., Ltd. Method of relieving or avoiding side effect of steroid
US7893040B2 (en) * 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
ITRM20050547A1 (it) 2005-11-04 2007-05-05 Sooft Italia S R L Gel oftalmico composto da triamcinolone acetonide e da un polimero poliacrilico.
MX2010009974A (es) * 2008-03-11 2010-09-30 Alcon Res Ltd Suspensiones de acetonida de triamcinolona de baja viscosidad, altamente floculadas para inyeccion intravitrea.

Also Published As

Publication number Publication date
MX2010009974A (es) 2010-09-30
EP2262506A1 (en) 2010-12-22
ZA201005839B (en) 2011-10-26
EP2262506B1 (en) 2014-05-07
BRPI0909630B1 (pt) 2019-03-26
DK2262506T3 (da) 2014-06-10
JP5581227B2 (ja) 2014-08-27
TW200940071A (en) 2009-10-01
TWI468165B (zh) 2015-01-11
US20090233890A1 (en) 2009-09-17
SI2262506T1 (sl) 2014-07-31
BRPI0909630A2 (pt) 2015-09-22
US20120115829A1 (en) 2012-05-10
CN101959519B (zh) 2013-03-20
US20120116216A1 (en) 2012-05-10
RU2481842C2 (ru) 2013-05-20
BRPI0909630B8 (pt) 2021-05-25
KR20100127267A (ko) 2010-12-03
PT2262506E (pt) 2014-06-24
AU2009223649B2 (en) 2013-08-29
WO2009114521A1 (en) 2009-09-17
JP2011513492A (ja) 2011-04-28
US8128960B2 (en) 2012-03-06
AU2009223649A1 (en) 2009-09-17
CN101959519A (zh) 2011-01-26
UY31699A1 (es) 2009-05-29
CL2009000573A1 (es) 2010-01-04
AR070824A1 (es) 2010-05-05
CA2717605C (en) 2012-05-15
ES2471122T3 (es) 2014-06-25
RU2010141542A (ru) 2012-04-20
US8211880B2 (en) 2012-07-03
CA2717605A1 (en) 2009-09-17
KR101555293B1 (ko) 2015-10-06
PL2262506T3 (pl) 2014-09-30

Similar Documents

Publication Publication Date Title
HK1146464A1 (en) Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
IL212919A0 (en) Low viscosity highly concentrated suspensions
EP2282735A4 (en) COMPOUNDS, COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
HK1159622A1 (en) 7-piperidinoalkyl-3,4-dihydroquinolone derivative 7--34-
AP2011005725A0 (en) Lactams as beta secretase inhibitors.
SI2356123T1 (sl) Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
GB0725321D0 (en) Delivery vehicles
IL216865A0 (en) Aptamer for chymase, compositions comprising the same and uses thereof
ZA201100797B (en) Electrodepositable composition
EP2334424A4 (en) VISCOSITY REDUCTION
AP2011005732A0 (en) 3-aminocyclopentanecarboxamides as chemokine receptor modulators.
EP2403896A4 (en) POLYAMIDE OF LIGHT VISCOSITY
GB0812513D0 (en) Delivery vehicle
ITRM20070080A1 (it) Lieviti per spumantizzazione.
EP2367935A4 (en) Acidothermus cellulolyticus-XYLANASE
PL2172383T3 (pl) Korytarz przejścia wewnętrznego pomiędzy dwoma pojazdami
HK1115711A2 (en) Cap
GB0809709D0 (en) Dunhill car,2093
GB0813815D0 (en) Corcost Pre 1001,10
IL188627A0 (en) Classified-lahaim.com
AU3841P (en) Passion Ptilotus nobilis
GB0810164D0 (en) Wedge-dek, shower-floor gradient-former
AP00176S1 (en) Bottle.
GB0819226D0 (en) New rail (N.R.)
AU2008906512A0 (en) Capping element